Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XV.c

Path: Organizing pneumonia (OP/BOOP) pattern (see also Id)

Publications

Huang PH, Kuo CJ, Lin CW, Cheng YM, Hu HC, Lin CY, Su MY, Chiu CT

Mesalazine-related lung disease in a patient with ulcerative colitis: A case report.

Medicine. 2018;97(48):e13242

Michy B, Raymond S, Graffin B

[Organizing pneumonia during treatment with mesalazine].

Revue des maladies respiratoires. 2014;31(1):70-7

Yano S, Kobayashi K, Kato K, Nishimura K

A limited form of Wegener's granulomatosis with bronchiolitis obliterans organizing pneumonitis-like variant in an ulcerative colitis patient.

Internal medicine (Tokyo, Japan). 2002;41(11):1013-5